Delivery Order SPE2DB22D1202-SPE2DB25FUGY7

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a $1,899.80 delivery order, is for the supply of Methylphenidate ER (long-acting) 10mg capsules. The contract has an ultimate completion date of April 15, 2025 and utilizes a firm fixed price pricing type. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $1,464.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a prime contractor and subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,563,905,554 units of Methylphenidate ER (long-acting) 10mg capsules, with a completion date of March 11, 2024. The contract is a firm fixed-price Delivery Order with no set-aside designation. Amerisourcebergen Drug Corp also holds an Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,557,327 units of Methylphenidate ER (long-acting) 10mg capsules, with a total ceiling value of $1,188.90. The contract is a Firm Fixed Price Delivery Order, with a period of performance ending on March 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,428.07, is a delivery order to supply the government with 4567489416 - Methylphenidate ER (long-acting) 10mg capsules. The contract has a completion date of March 7, 2025 and uses a firm fixed price pricing type. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,542.62 and an ultimate completion date of June 25, 2025. The contract is for the delivery of 100 units of the medication Methylphenidate ER (long-acting) 10mg capsules. This contract is not a set-aside. AmerisourceBergen Drug Corp also holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,518.96 firm fixed-price delivery order is for the supply of 100 units of Methylphenidate ER (LA) 10mg capsules. The contract has a completion date of June 18, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,741.00, is for the delivery of 4,565,795,693 units of the medication Methylphenidate ER (long-acting) 10 mg capsules. The contract has a firm fixed price pricing type and does not have any set-aside designation, indicating open competition. The place of performance is Conshohocken, PA. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for Methylphenidate ER (long-acting) 30mg capsules, with a ceiling value of $1,249.74 and a performance period ending on May 29, 2025. The contract is a firm-fixed price arrangement and is not a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of 4,566,443,540 units of Methylphenidate ER (long-acting) 30mg capsules, placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,087.96 firm fixed-price delivery order has a completion date of November 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, covering a wide range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,502,453 units of methylphenidate ER 18 mg tablets in 100-count bottles. The $1,519.44 firm fixed-price Delivery Order (DO) has a completion date of November 21, 2024 and is not subject to any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUGY7
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price valued at $1,163.01 and covers the supply of Methylphenidate ER (long-acting) 10mg capsules. The contract has an ultimate completion date of October 31, 2024.

AmerisourceBergen is the prime contractor and holds two Indefinite Delivery Contracts (IDCs) with DLA and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and $750,000 respectively. These IDCs serve as primary vehicles for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, as well as other federal medical institutions. The contract award does not have a set-aside designation, indicating open competition.

Generated 1/29/25, 9:20 AM